Dermira, Inc. IPO Research Information

Dermira, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Dermira, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Dermira, Inc.	DERM - NASDAQ	$14.00-$16.00	$16.00	$18.00	7.8 million	10/3/2014
Underwriter(s): Citigroup, Leerink Partners
Co-Manager(s): Guggenheim Securities, Needham & Company
Industry: Health Care
Filing(s): Filed 2014-08-27 Terms Added 2014-09-19 Amended Terms 2014-10-01

Dermira, Inc. Quote & Chart - Click for current quote - DERM

About Dermira, Inc. (adapted from Dermira, Inc. prospectus):
They are a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients.

This description is adapted from Dermira prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Dermira "DERM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.